Skip to main content
. Author manuscript; available in PMC: 2018 Jan 28.
Published in final edited form as: AIDS. 2017 Jan 28;31(3):385–393. doi: 10.1097/QAD.0000000000001345

Table 3.

Associations of markers of microbial translocation, monocyte activation, and inflammation with HOMA-IR by HIV and HCV status

Parameter HOMA-IR Unadjusted HOMA-IR Demographic-adjusted* HOMA-IR Fully adjusted**
% Estimate (95% CI) % Estimate (95% CI) % Estimate (95% CI)
HIV/HCV coinfected
 I-FABP (per doubling) −3% (−11%, 5%) p=0.428 −8% (−15%, 0%) p=0.044 −5% (−12%, 2%) p=0.174
 sCD163 (per doubling)§ 30% (17%, 45%) p<0.001 25% (12%, 40%) p<0.001 19% (7%, 33%) p=001
 sCD14 (per doubling)§ −11% (−18%, −4%) p=0.002 −9% (−15%, −2%) p=0.014 0% (−6%, 8%) p=0.833
 1L-6 (per doubling)§ 1% (−7%, 8%) p=0.884 2% (−5%, 11%) p=0.510 1% (−6%, 9%) p=0.758
HCV monoinfected
 I-FABP (per doubling) −2% (−10%, 6%) p=0.597 −7% (−14%, 1%) p=0.097 −3% (−10%, 4%) P=0.397
 sCD163 (per doubling)§ 30% (18%, 44%) p<0.001 28% (16%, 42%) p<0.001 26% (15%, 39%) p<0.001
 sCD14 (per doubling)§ −9% (−14%, 0%) p=0.025 −7% (−14%, 0%) p=0.61 4% (−4%, 12%) p=−0.341
 1L-6 (per doubling)§ 3% (−4%, 12%) p=0.392 4% (−4%, 13%) p=0.279 3% (−4%, 10%) P=0.359
HIV monoinfected
 I-FABP (per doubling) −1% (−9%, 8%) p=0.931 −6% (−14%, 2%) p=0.182 −3% (−10%, 5%) p=0.49
 sCD163 (per doubling)§ 28% (16%, 41%) p<0.001 26% (14%, 39%) p<0.001 25% (14%, 37%) p<0.001
 sCD14 (per doubling)§ −8% (−14%, 0%) p=0.051 −6% (−13%, 1%) p=0.089 1% (−6%, 10%) p=0.688
 IL-6 (per doubling)§ 3% (−5%, 10%) p=0.473 3% (−4%, 14%) p=0.343 3% (−4%, 11%) p=0.387
Uninfected
 I-FABP (per doubling) −3% (−11%, 6%) p=0.560 −8% (−16%, 0%) p=0.052 −6% (−14%, 2%) p=0.113
 sCD163 (per doubling)§ 34% (21%, 49%) p<0.001 29% (16%, 43%) p<0.001 23% (11%, 36%) p=001
 sCD14 (per doubling)§ −10% (−16%, −3%) p=0.009 −9% (−15%, −2%) p=0.014 −4% (−8%, 6%) p=0.684
 1L-6 (per doubling)§ 3% (−4%, 12%) p=0.398 4% (−4%, 12%) p=0.302 3% (−5%, 10%) p=0.493

Multiple imputation by the Chained Equation method was used to impute missing outcome values

*

Adjusted for gender, age, race

**

Adjusted for age, gender, race, smoking, alcohol, BMI, waist circumference and estimated glomerular filtrate rate.

§

All markers of inflammation added individually not sequentially.